Under IAVI's agreement with Merck KGaA and Serum Institute, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies.
At present, vaccine candidates by Bharat Biotech, Serum Institute of India (Oxford University-AstraZeneca), and Zydus Cadila are under advanced stages of trials.
The minister also said that the government is keeping an eye on immunity data with regard to Covid-19 disease while finalizing these plans, as reported by this newspaper earlier.
The central health ministry official said that they have not received any official proposal from the institute regarding mass production, procurement, and distributions of the vaccine.
'All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some,' said Dr Murlidhar Tambe.
Under phase-II, trials had been conducted at the Bharti Vidyapeeth Medical College and also KEM Hospital in the city.
Under phase-II, trials were conducted at Bharti Vidyapeeth Medical College and also KEM Hospital in the city.
Under PM Modi's guidance, an expert group is looking at it and we have advanced planning in place, the Union Health Minister said.
SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.
The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.
However, speaking to TNIE, B Suresh, Pro Chancellor of JSS AHER, said that so far, none among their 32 volunteers have reported any adverse reactions and all are doing fine.
India will continue Oxford vaccine trial, says Serum Institute after illness in volunteer pauses trial abroad
Serum Institute of India, under whose aegis the vaccine is to be being tried on 1,600 participants across 17 centres, said that trials in India will continue, irrespective of the latest development.
In all, 25 candidates will be given the vaccine in the next seven days.
Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.
The vaccine candidate is under advanced stages of clinical trials and likely to be available for public use in the first half of 2021.